相关实验视频

Updated: Jul 27, 2025

Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts

Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts

Published on: September 1, 2018

利用I型干扰素介导免疫来准恶性脑瘤

Juhee Lim¹, In Kang¹, Jeongwoo La¹

¹Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology (KAIST), Daejeon, Republic of Korea.

Frontiers in immunology

|June 12, 2023

概括

I型干扰素对抗病毒免疫非常重要,并且越来越多地被认为是它们在抗瘤反应中的作用. 这篇评论探讨了这些干扰素如何将质瘤中的免疫抑制性瘤微环境转化为免疫激活的微环境,为新的脑瘤免疫疗法铺平了道路.

科学领域:

免疫学免疫学免疫学
神经瘤学神经瘤学
细胞因子生物学

背景情况:

I型干扰素 (IFN) 是抗病毒免疫的关键调节剂.
新出现的证据强调它们在调节抗瘤免疫反应中的重要作用.
瘤微环境 (TME) 通常具有免疫抑制作用,阻碍有效的抗癌免疫力.

研究的目的:

审查I型IFN在调节脑瘤微环境中的抗瘤免疫力中的作用,特别是质瘤.
探索I型IFN如何将"冷" (非免疫原) TME转化为"热" (免疫激活) TME.
讨论针对脑瘤免疫疗法的基于IFN的I型策略的转化潜力.

主要方法:

文献综述侧重于1型IFN在质瘤的免疫功能.
分析I型IFN对免疫细胞透和大脑TME中的活动的影响.
综合关于质瘤免疫学和治疗策略的当前知识.

主要成果:

I型IFN刺激瘤透的淋巴细胞,增强质瘤细胞的免疫清除.
这些细胞因子可以重新编程免疫抑制性脑TME,促进抗质瘤免疫反应.
第一种类型的IFN对于调节大脑对抗质瘤的免疫场景至关重要.

结论:

I型干扰素对克服恶性质瘤中免疫抑制性TME具有显著的前景.
了解I型IFN介导的免疫调节对于开发针对脑瘤的有效免疫疗法至关重要.
针对I型IFN可能代表着一种新的治疗途径,用于质瘤患者.

关键词:

大脑瘤大脑瘤质母细胞瘤是什么免疫疗法免疫疗法瘤微环境是一个微环境.第一种类型的干扰子干扰子.

更多相关视频

Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells

Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells

Published on: November 28, 2015

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.